Spectral AI Named to TIME’s List of World’s Top HealthTech Companies 2025
Spectral AI (Nasdaq: MDAI), a medical diagnostics company specializing in AI-powered wound care solutions, has been recognized on TIME's World's Top HealthTech Companies 2025 list. The prestigious ranking, published on September 18, 2025, features 400 leading healthcare technology innovators selected from thousands of companies globally.
Companies were evaluated based on three key criteria: financial performance, reputation analysis, and online engagement. The recognition highlights Spectral AI's progress in developing their DeepView technology as they work towards global commercialization of their AI-based predictive wound care solutions.
Spectral AI (Nasdaq: MDAI), un’azienda di diagnostica medica specializzata in soluzioni di cura delle ferite alimentate dall’IA, è stata riconosciuta nella lista TIME's World's Top HealthTech Companies 2025. La prestigiosa classifica, pubblicata il 18 settembre 2025, presenta 400 innovatori leader nel campo della tecnologia sanitaria selezionati tra migliaia di aziende a livello globale.
Le aziende sono state valutate in base a tre criteri chiave: performance finanziaria, analisi della reputazione e coinvolgimento online. Il riconoscimento mette in evidenza i progressi di Spectral AI nello sviluppo della loro tecnologia DeepView, mentre lavorano verso la commercializzazione globale delle loro soluzioni di cura delle ferite predittive basate sull’IA.
Spectral AI (Nasdaq: MDAI), una empresa de diagnóstico médico especializada en soluciones de cuidado de heridas impulsadas por IA, ha sido reconocida en la lista TIME's World's Top HealthTech Companies 2025. El prestigioso ranking, publicado el 18 de septiembre de 2025, presenta a 400 innovadores líderes en tecnología de la salud seleccionados entre miles de empresas a nivel mundial.
Las empresas fueron evaluadas en función de tres criterios clave: desempeño financiero, análisis de reputación y participación en línea. El reconocimiento destaca los avances de Spectral AI en el desarrollo de su tecnología DeepView mientras trabajan hacia la comercialización global de sus soluciones de cuidado de heridas predictivas basadas en IA.
Spectral AI (나스닥: MDAI), AI 기반 상처 관리 솔루션을 전문으로 하는 의료 진단 회사가 TIME의 World’s Top HealthTech Companies 2025 목록에 선정되었습니다. 2025년 9월 18일에 발표된 이 권위 있는 순위는 전 세계 수천 개 기업 중에서 선정된 400개의 선도적인 헬스케어 기술 혁신 기업을 포함합니다.
기업은 세 가지 핵심 기준에 따라 평가되었습니다: 재무 성과, 명성 분석, 온라인 참여. 이 인정은 AI 기반 예측 상처 관리 솔루션의 글로벌 상용화를 향해 나아가고 있는 DeepView 기술 개발에 있어 Spectral AI의 진전을 강조합니다.
Spectral AI ( Nasdaq: MDAI ), une entreprise de diagnostics médicaux spécialisée dans les solutions de soins des plaies alimentées par l’IA, a été reconnue sur la liste TIME's World's Top HealthTech Companies 2025. Le classement prestigieux, publié le 18 septembre 2025, compte 400 innovateurs majeurs dans le domaine de la technologie de la santé sélectionnés parmi des milliers d’entreprises dans le monde.
Les entreprises ont été évaluées selon trois critères clés : performance financière, analyse de la réputation et engagement en ligne. Cette reconnaissance met en lumière les progrès de Spectral AI dans le développement de leur technologie DeepView alors qu’ils travaillent à la commercialisation mondiale de leurs solutions de soins des plaies prédictifs basées sur l’IA.
Spectral AI (Nasdaq: MDAI), ein Unternehmen für medizinische Diagnostik, das sich auf KI-gesteuerte Wundversorgungslösungen spezialisiert hat, wurde auf die Liste TIME's World's Top HealthTech Companies 2025 aufgenommen. Die prestigeträchtige Rangliste, veröffentlicht am 18. September 2025, umfasst 400 führende Innovatoren im Gesundheits-Tech-Bereich, ausgewählt aus Tausenden von Unternehmen weltweit.
Unternehmen wurden anhand von drei Schlüsselkriterien bewertet: finanzielle Performance, Reputationsanalyse und Online-Interaktion. Die Anerkennung unterstreicht Spectral AIs Fortschritte bei der Entwicklung ihrer DeepView-Technologie, während sie auf die weltweite Vermarktung ihrer KI-basierten prädiktiven Wundversorgungs-Lösungen hinarbeiten.
Spectral AI (ناسداك: MDAI)، شركة تشخيص طبي تتخصص في حلول رعاية الجروح مدعومة بالذكاء الاصطناعي، قد تم الاعتراف بها في قائمة TIME's World's Top HealthTech Companies 2025. التصنيف المرموق، المنشور في 18 سبتمبر 2025، يضم 400 مبتكر رائد في تكنولوجيا الرعاية الصحية من بين آلاف الشركات حول العالم.
تم تقييم الشركات بناءً على ثلاثة معايير رئيسية: الأداء المالي، تحليل السمعة، والتفاعل عبر الإنترنت. يبرز هذا الاعتراف تقدم Spectral AI في تطوير تقنيتهم DeepView بينما يعملون نحو تسويق عالمي لحلول رعاية الجروح التنبؤية المعتمدة على الذكاء الاصطناعي.
Spectral AI（纳斯达克股票代码：MDAI），一家专注于 AI 驱动伤口护理解决方案的医疗诊断公司，已入选 TIME 的 2025 年全球最佳健康科技公司榜单。该享有盛誉的排行榜于 2025 年 9 月 18 日发布，来自全球数千家公司的 400 位领先医疗科技创新者上榜。
公司评估基于 三个关键标准：财政表现、声誉分析以及线上参与度。此项认可凸显 Spectral AI 在开发其 DeepView 技术方面的进展，同时他们正朝着 AI 驱动的预测性伤口护理解决方案的全球商业化迈进。
- None.
- None.
DALLAS, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced it has been named to TIME’s World’s Top HealthTech Companies 2025 list. The ranking, released September 18, 2025, can be viewed on Time.com.
The list, compiled by TIME and Statista Inc., recognizes leading innovators advancing healthcare globally through technology. Companies were evaluated on financial performance, reputation analysis, and online engagement. Out of thousands of HealthTech companies reviewed, 400 were recognized for their outstanding performance across these categories.
J. Michael DiMaio, M.D., Chairman of Spectral AI, said, “Being named to TIME’s World’s Top HealthTech Companies 2025 list alongside so many great companies is a huge milestone for Spectral AI and our DeepView technology. This recognition underscores the progress our team has made as we work toward global commercialization. Every team member continues to strive to deliver our innovative AI-based predictive wound care technology to the medical community.”
About Spectral AI
Spectral AI, Inc. is a Dallas-based predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns. The Company is working to revolutionize the management of wound care by “Seeing the Unknown®” with its DeepView System. The DeepView System is being developed as a predictive device to offer clinicians an objective and immediate assessment of a burn wound’s healing potential prior to treatment or other medical intervention. With algorithm-driven results and a goal of exceeding the current standard of care in the future, the DeepView System is expected to provide fast and accurate treatment insight towards value care by improving patient outcomes and reducing healthcare costs. For more information about the DeepView System, visit www.spectral-ai.com.
Forward-Looking Statements
Certain statements made in this release are “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995, including statements regarding the Company’s strategy, plans, objectives, initiatives and financial outlook. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside of the Company’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. As such, readers are cautioned not to place undue reliance on any forward-looking statements.
Investors should carefully consider the foregoing factors, and the other risks and uncertainties described in the “Risk Factors” sections of the Company’s filings with the SEC, including the Registration Statement and the other documents filed by the Company. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements.
For Media and Investor Relations, please contact:
David Kugelman
Atlanta Capital Partners LLC
(866) 692-6847 Toll Free - U.S. & Canada
(404) 281-8556 Mobile and WhatsApp
Email: dk@atlcp.com
FAQ
What is Spectral AI's (MDAI) main business focus?
Why was Spectral AI selected for TIME's Top HealthTech Companies 2025 list?
When was Spectral AI named to TIME's HealthTech list?
What is Spectral AI's DeepView technology?
